Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Therapeutic Drug Monitoring|January 1, 1989
Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian modelsR D Pryka, K A Rodvold, M Garrison, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Effect of cardiopulmonary bypass on vancomycin and netilmicin dispositionK J Klamerus, K A Rodvold, N A Silverman, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1999
In-vitro synergy of paromomycin with metronidazole alone or metronidazole plus hydroxymetronidazole against Helicobacter pyloriJ M Meyer, S Ryu, S L Pendland, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteersK A Rodvold, M H Gotfried, L H Danziger, et al.
Pharmacotherapy|June 13, 2001
Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecium [correction of faecalis] ventriculitisK W Garey, E Tesoro, V Muggia, et al.
DICP : the Annals of Pharmacotherapy|March 1, 1990
Clinical pharmacokinetics of daptomycinR D Pryka, R M Novak, D K Wagner, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Pharmacokinetics of intramuscularly administered aminosidine in healthy subjectsT P Kanyok, A D Killian, K A Rodvold, et al.
Clinical Pharmacology and Therapeutics|May 1, 1993
Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancerS C Piscitelli, K A Rodvold, D A Rushing, et al.
Therapeutic Drug Monitoring|June 19, 1998
Therapeutic drug monitoring of vancomycin in a morbidly obese patientS R Penzak, P O Gubbins, K A Rodvold, et al.
The Annals of Pharmacotherapy|May 1, 1995
Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combinationL L Schoonover, D J Occhipinti, K A Rodvold, et al.
Pageof 10